A Randomized, Controlled Dose-Finding Phase II Study of the M72/AS01 Candidate Tuberculosis Vaccine in Healthy PPD-Positive Adults
出版年份 2013 全文链接
标题
A Randomized, Controlled Dose-Finding Phase II Study of the M72/AS01 Candidate Tuberculosis Vaccine in Healthy PPD-Positive Adults
作者
关键词
Tuberculosis, vaccine, M72 antigen, AS01, CD4<sup>+</sup> T cells
出版物
JOURNAL OF CLINICAL IMMUNOLOGY
Volume 33, Issue 8, Pages 1360-1375
出版商
Springer Nature
发表日期
2013-10-19
DOI
10.1007/s10875-013-9949-3
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- The candidate tuberculosis vaccine Mtb72F/AS02A: Tolerability and immunogenicity in humans
- (2014) Kenneth Von Eschen et al. Human vaccines & immunotherapeutics
- A Phase IIa Trial of the New Tuberculosis Vaccine, MVA85A, in HIV- and/orMycobacterium tuberculosis–infected Adults
- (2012) Thomas J. Scriba et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- The Importance of Adjuvant Formulation in the Development of a Tuberculosis Vaccine
- (2012) S. L. Baldwin et al. JOURNAL OF IMMUNOLOGY
- The candidate tuberculosis vaccine Mtb72F/AS02 in PPD positive adults: A randomized controlled phase I/II study
- (2012) François Spertini et al. TUBERCULOSIS
- Improved CD4+ T cell responses to Mycobacterium tuberculosis in PPD-negative adults by M72/AS01 as compared to the M72/AS02 and Mtb72F/AS02 tuberculosis candidate vaccine formulations: A randomized trial
- (2012) Isabel Leroux-Roels et al. VACCINE
- Vaccines against Tuberculosis: Where Are We and Where Do We Need to Go?
- (2012) Tom H. M. Ottenhoff et al. PLoS Pathogens
- Recent clinical experience with vaccines using MPL- and QS-21-containing Adjuvant Systems
- (2011) Nathalie Garçon et al. Expert Review of Vaccines
- Dose-Finding Study of the Novel Tuberculosis Vaccine, MVA85A, in Healthy BCG-Vaccinated Infants
- (2011) Thomas J. Scriba et al. JOURNAL OF INFECTIOUS DISEASES
- A multistage tuberculosis vaccine that confers efficient protection before and after exposure
- (2011) Claus Aagaard et al. NATURE MEDICINE
- BCG sub-strains induce variable protection against virulent pulmonary Mycobacterium tuberculosis infection, with the capacity to drive Th2 immunity
- (2011) Andrew Keyser et al. VACCINE
- The Novel Tuberculosis Vaccine, AERAS-402, Induces Robust and Polyfunctional CD4+and CD8+T Cells in Adults
- (2010) Brian Abel et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Specific T Cell Frequency and Cytokine Expression Profile Do Not Correlate with Protection against Tuberculosis after Bacillus Calmette-Guérin Vaccination of Newborns
- (2010) Benjamin M. N. Kagina et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Evaluation of the Safety and Immunogenicity of Two Antigen Concentrations of the Mtb72F/AS02A Candidate Tuberculosis Vaccine in Purified Protein Derivative-Negative Adults
- (2010) I. Leroux-Roels et al. Clinical and Vaccine Immunology
- Multifunctional CD4+ T cells correlate with active Mycobacterium tuberculosis infection
- (2010) Nadia Caccamo et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- H5N1 Influenza Vaccine Formulated with AS03A Induces Strong Cross-Reactive and Polyfunctional CD4 T-Cell Responses
- (2010) Philippe Moris et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Expanded Polyfunctional T Cell Response to Mycobacterial Antigens in TB Disease and Contraction Post-Treatment
- (2010) James M. Young et al. PLoS One
- A Longitudinal Study of BCG Vaccination in Early Childhood: The Development of Innate and Adaptive Immune Responses
- (2010) Yenny Djuardi et al. PLoS One
- Safety and Immunogenicity of a New Tuberculosis Vaccine, MVA85A, inMycobacterium tuberculosis–infected Individuals
- (2009) Clare R. Sander et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- The protective role of antibody responses duringMycobacterium tuberculosisinfection
- (2009) F. Abebe et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- The quest for biomarkers in tuberculosis
- (2009) Shreemanta K. Parida et al. DRUG DISCOVERY TODAY
- Modified vaccinia Ankara-expressing Ag85A, a novel tuberculosis vaccine, is safe in adolescents and children, and induces polyfunctional CD4+ T cells
- (2009) Thomas J. Scriba et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Quality and Vaccine Efficacy of CD4+ T Cell Responses Directed to Dominant and Subdominant Epitopes in ESAT-6 from Mycobacterium tuberculosis
- (2009) C. S. Aagaard et al. JOURNAL OF IMMUNOLOGY
- Tuberculosis Subunit Vaccination Provides Long-Term Protective Immunity Characterized by Multifunctional CD4 Memory T Cells
- (2009) T. Lindenstrom et al. JOURNAL OF IMMUNOLOGY
- Distinct Differences in the Expansion and Phenotype of TB10.4 Specific CD8 and CD4 T Cells after Infection with Mycobacterium tuberculosis
- (2009) Truc Thi Kim Thanh Hoang et al. PLoS One
- Protection and Polyfunctional T Cells Induced by Ag85B-TB10.4/IC31® against Mycobacterium tuberculosis Is Highly Dependent on the Antigen Dose
- (2009) Claus Aagaard et al. PLoS One
- Complex cytokine profiles induced by BCG vaccination in UK infants
- (2009) Maeve K. Lalor et al. VACCINE
- Persistence of the immune response induced by BCG vaccination
- (2008) Rosemary E Weir et al. BMC INFECTIOUS DISEASES
- Mycobacterium tuberculosis-specific CD4+, IFNγ+, and TNFα+ multifunctional memory T cells coexpress GM-CSF
- (2008) Henrik Mueller et al. CYTOKINE
- Standardization and optimization of multiparameter intracellular cytokine staining
- (2008) Laurel Nomura et al. CYTOMETRY PART A
- Safety and Immunogenicity of a New Tuberculosis Vaccine, MVA85A, in Healthy Adults in South Africa
- (2008) Tony Hawkridge et al. JOURNAL OF INFECTIOUS DISEASES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started